Flow-mediated vasodilation in end-stage renal disease

Area of Science:

• Cardiovascular Physiology
• Renal Medicine
• Endothelial Biology

Background:

• Endothelial dysfunction is a hallmark of various cardiovascular diseases (CVD) and end-stage renal disease (ESRD).
• The endothelium's role in regulating arterial vasomotor tone and shear stress (SS) is crucial for cardiovascular health.

Purpose of the Study:

• To investigate the independent and combined effects of ESRD and CVD on flow-mediated vasodilation (FMD).
• To analyze the impact of uremia versus CVD on SS-mediated brachial artery diameter changes.

Main Methods:

• Progressive hand-warming protocol to induce shear stress (SS).
• Repeated measures ANOVA to analyze brachial artery diameter changes (ΔBA) in healthy controls, ESRD patients without CVD (ESRD-CVD(-)), and ESRD patients with CVD (ESRD-CVD(+)).

Main Results:

• Both ESRD and CVD(+) were independently associated with reduced ΔBA (endothelial dysfunction).
• ESRD-CVD(-) patients showed reduced ΔBA at higher SS compared to controls.
• ESRD-CVD(+) patients exhibited blunted or paradoxical vasoconstriction in response to SS.
• 25(OH) vitamin D(3) insufficiency was independently linked to reduced ΔBA in ESRD patients.

Conclusions:

• ESRD and a history of CVD independently contribute to endothelial dysfunction.
• Clinical assessment should consider the interplay between SS, endothelial function, ESRD, and CVD.
• Vitamin D status may be a modifiable factor in ESRD-related endothelial dysfunction.